There are not two sides to the truth. One side is
Post# of 144829
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
It is dangerous thinking to say that there are always two sides. How about this one?
1) Leronlimab showed efficacy in a subset of critically ill people in the clinical trial, but they only got 2 doses because the FDA wouldn't let them do the 4-dose regimen. Therefore continuing with clinical trials, with the knowledge gained from this trial, and using the 4-dose regimen, is warranted.
2) The FDA says Leronlimab failed all its endpoints, therefore it is garbage that should be abandoned.
Do those "two sides" have equal validity?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)